Matthew Kulke, MD | FDA Approves Carcinoid Syndrome drug
3,005 views · Published 28 February 2017 · 2:09 · Indexed 26 October 2026
Channel: Dana-Farber Cancer Institute · 2017 · Science & Technology
Dr. Matthew H. Kulke, Director of the Neuroendocrine and Carcinoid Tumors program at Dana-Farber, talks about his research that led the Food and Drug Administration (FDA) to approve the first drug to treat patients with Carcinoid Syndrome in decades.
More from this channel
-
0:18
Importance of Joining the Stem Cell Registry | Dana-Farber Cancer Institute
-
0:20
How to Join the Stem Cell Registry | Dana-Farber Cancer Institute
-
0:18
How to Register as a Stem Cell Donor | Dana-Farber Cancer Institute
-
3:03
Sportscaster Jim Britt for the Jimmy Fund | Dana-Farber Cancer Institute
-
0:07
Dana-Farber Banners | Dana-Farber Cancer Institute
-
2:08
Barbers for the Jimmy Fund | Dana-Farber Cancer Institute
-
1:43
Pets | Dana-Farber Cancer Institute
-
1:34
Healthy Eating for the Holiday Season | Dana-Farber Cancer Institute